CureVac

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CureVac and other ETFs, options, and stocks.

About CVAC

CureVac BV is a clinical-stage biopharmaceutical company, which engages in developing transformative medicines based on messenger ribonucleic acid (mRNA). Its product portfolio includes clinical and preclinical candidates across multiple disease indications in prophylactic vaccines, oncology, and protein therapy.

CEO

Alexander Zehnder

CEOAlexander Zehnder

Employees

983

Employees983

Headquarters

Tübingen, Baden Wuerttemberg

HeadquartersTübingen, Baden Wuerttemberg

Founded

2020

Founded2020

Employees

983

Employees983

CVAC Key Statistics

Market cap

1.23B

Market cap1.23B

Price-Earnings ratio

6.00

Price-Earnings ratio6.00

Dividend yield

—

Dividend yield—

Average volume

962.89K

Average volume962.89K

High today

$5.45

High today$5.45

Low today

$5.38

Low today$5.38

Open price

$5.38

Open price$5.38

Volume

750.03K

Volume750.03K

52 Week high

$5.72

52 Week high$5.72

52 Week low

$2.37

52 Week low$2.37

Analyst ratings

86%

of 7 ratings

Buy

14.3%

Hold

85.7%

Sell

People also own

Based on the portfolios of people who own CVAC. This list is generated using Robinhood data, and it’s not a recommendation.